Kuroda K, Gröner A, Frese K, Drenckhahn D, Hauser C, Rott R, Doerfler W, Klenk H D
Institute für Virologie, Philipps-Universität, Marburg, Federal Republic of Germany.
J Virol. 1989 Apr;63(4):1677-85. doi: 10.1128/JVI.63.4.1677-1685.1989.
The hemagglutinin of influenza (fowl plague) virus was expressed in larvae of Heliothis virescens by using recombinant Autographa californica nuclear polyhedrosis virus (AcNPV) as a vector. Animals were infected with the recombinant virus either by parenteral injection or by feeding. For oral uptake, recombinant virus occluded in polyhedra obtained from cultured Spodoptera frugiperda cells after coinfection with authentic AcNPV was used. Immunohistological analyses of infected animals revealed that the hemagglutinin was expressed only in those tissues that are also permissive for the replication of authentic AcNPV. These tissues included hypodermis, fat body, and tracheal matrix. After oral infection, hemagglutinin was also detected in individual gut cells. The amount of hemagglutinin synthesized in larvae after parenteral infection was 0.3% of the total protein, compared with 5% obtained in cultured insect cells. The hemagglutinin was transported to the cell surface and expressed in polarized cells only at the apical plasma membrane. It was processed by posttranslational proteolysis into the cleavage products HA1 and HA2. Oligosaccharides were attached by N-glycosidic linkages and were smaller than those found on hemagglutinin obtained from vertebrate cells. Hemagglutinin from larvae expressed receptor binding and cell fusion activities, but quantitation of the hemolytic capacity revealed that it was only about half as active as hemagglutinin from vertebrate or insect cell cultures. Chickens immunized with larval tissues containing hemagglutinin were protected from infection with fowl plague virus. These observations demonstrate that live insects are able to produce a recombinant membrane protein of vertebrate origin in biologically active form.
利用重组苜蓿银纹夜蛾核型多角体病毒(AcNPV)作为载体,在甜菜夜蛾幼虫中表达了流感(禽瘟)病毒的血凝素。通过皮下注射或喂食的方式用重组病毒感染动物。对于口服摄取,使用与正宗AcNPV共感染后从培养的草地贪夜蛾细胞中获得的包埋在多角体中的重组病毒。对感染动物的免疫组织学分析表明,血凝素仅在那些也允许正宗AcNPV复制的组织中表达。这些组织包括皮下组织、脂肪体和气管基质。口服感染后,在个别肠道细胞中也检测到了血凝素。皮下感染后幼虫中合成的血凝素量占总蛋白的0.3%,而在培养的昆虫细胞中获得的为5%。血凝素被转运到细胞表面,仅在顶端质膜的极化细胞中表达。它通过翻译后蛋白水解加工成裂解产物HA1和HA2。寡糖通过N-糖苷键连接,并且比从脊椎动物细胞获得的血凝素上发现的寡糖小。来自幼虫的血凝素表现出受体结合和细胞融合活性,但溶血能力的定量显示,其活性仅为来自脊椎动物或昆虫细胞培养物的血凝素的一半左右。用含有血凝素的幼虫组织免疫的鸡受到了保护,免受禽瘟病毒感染。这些观察结果表明,活昆虫能够产生具有生物活性形式的脊椎动物来源的重组膜蛋白。